Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy.
Mayo Clin Proc
; 97(7): 1294-1304, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35787856
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Acute Kidney Injury
/
Receptors, Chimeric Antigen
/
Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Mayo Clin Proc
Year:
2022
Document type:
Article
Affiliation country:
Mongolia
Country of publication:
Reino Unido